Market Overview

UPDATE: ISI Group Initiates CVS Caremark at Overweight, $53.50 PT

Share:
Related CVS
Analysts At Argus Review CVS Q2 Earnings
Fantastic Yields And Where To Find Them: Top 3 Yields From The Dow 30
The Vetr community has upgraded $CVS to 5-Stars. (Vetr)

ISI Group initiated its coverage on CVS Caremark (NYSE: CVS) with a rating of Overweight and a price target of $53.50.

ISI Group commented, "Our thesis for CVS is based on our view of continued share gain at the pharmacy given the success of Maintenance Choice and the continuation of the WAG/ESRX dispute, improved growth and profitability at Caremark as a result of innovative solutions and the streamlining initiative, and a very shareholder friendly approach to capital deployment and enhanced capital returns."

CVS Caremark closed at $46.90 on Wednesday.

Latest Ratings for CVS

DateFirmActionFromTo
Aug 2016CitigroupMaintainsNeutral
Aug 2016Deutsche BankMaintainsHold
Jun 2016Morgan StanleyDowngradesEqual-weight

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (CVS)

View Comments and Join the Discussion!